The Allergy Relief Study

Participate in the Allergy Relief Study

Participate in a clinical study of a potential treatment for allergic rhinitis (AR), also known as hay fever. AR is caused by our immune system’s response to a benign allergen, like pollen or dust mites. While there are several treatment options available, they fail to provide permanent relief to many people with AR.

Nucleus Network is looking for men and women with ragweed allergy, havfever or fall allergies for a clinical trial for the investigational treatment for AR.

Call us 612-315-6490 for dates, details, or to check if you meet eligibility requirements.

What is the study drug?

In this study we are testing a potential new treatment that works by modulating how our immune system reacts to these allergens, with the goal of preventing the immune system from overreacting. The treatment will be administered as a nasal spray.

Who Can Participate:

• Healthy Adults, aged 18 – 64 years old
• This study involves a skin prick test to check for a ragweed allergy.
• BMI 18–32 kg/m2
• No significant medical history
• Non-smokers

Study duration: The study extends over 4 months and requires outpatient visits. Outpatient visits vary from 1-6 hours. Multiple start dates are available.

Reimbursement: $3,940

Schedule a call for more information using the calendar below!

Recruitment Direct Line: 612-315-6490

Schedule a call using the calendar below.